GBG HOME

GeparOcto: pCR in lymph nodes correlates with DFS

27.01.2022

Exploratory analysis of GeparOcto patients published in "Cancers"

pCR in breast and axillary lymph nodes after NAST in patients with initially pN+ correlates with DFS. Conversion to ypN0 is of high prognostic value.
Surgical axillary staging after NAST is still essential in these patients to offer tailored treatment.

Full text available

Gerber, B.et al. Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial. Cancers 2022, 14, 521. https://doi.org/10.3390/cancers14030521

News

GBG Forschungs GmbH
Dornhofstr. 10 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd